Network screening of Goto-Kakizaki rat liver microarray data during diabetic progression

BMC Systems Biology

Volumn 5, Issue SUPPL. 1, 2011, Pages

  Zhou, Huarong ^a   Saito, Shigeru ^b,c   Piao, Guanying ^a,d   Liu, Zhi Ping ^a   Wang, Jiguang ^a   Horimoto, Katsuhisa ^b,e   Chen, Luonan ^a,b,e  

^a Shanghai Jiao Tong University Affiliated Sixth People s Hospital   (China)

^b NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY AIST   (Japan)

^c INFOCOM Corporation   (Japan)

^d UNIVERSITY OF SCIENCE AND TECHNOLOGY OF CHINA   (China)

^e SHANGHAI UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

RATTUS;

ANIMAL; ARTICLE; DIABETES MELLITUS; DISEASE COURSE; DNA MICROARRAY; GENE EXPRESSION PROFILING; GENE REGULATORY NETWORK; GENETICS; IMMUNOLOGY; LIVER; MALE; METABOLISM; PATHOLOGY; RAT; SIGNAL TRANSDUCTION; SPECIES DIFFERENCE;

ANIMALS; DIABETES MELLITUS; DISEASE PROGRESSION; GENE EXPRESSION PROFILING; GENE REGULATORY NETWORKS; LIVER; MALE; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; RATS; SIGNAL TRANSDUCTION; SPECIES SPECIFICITY;

EID: 79959265839     PISSN: None     EISSN: 17520509     Source Type: Journal    
DOI: 10.1186/1752-0509-5-S1-S16     Document Type: Article

References (41)

1. Smyth S, Heron A. Diabetes and obesity: the twin epidemics. Nat Med 2006, 12:75-80. 10.1038/nm0106-75, 16397575.
2. Sladek R, Rocheleau G, Rung J, Dina C, Shen L, Serre D, Boutin P, Vincent D, Belisle A, Hadjadj S, Balkau B, Heude B, Charpentier G, Hudson TJ, Montpetit A, Pshezhetsky AV, Prentki M, Posner BI, Balding DJ, Meyre D, Polychronakos C, Froguel P. A genome-wide association study identifies novel risk loci for type 2 diabetes. Nature 2007, 445:881-885. 10.1038/nature05616, 17293876.
3. Hetherington MM, Cecil JE. Gene-environment interactions in obesity. Forum Nutr 2010, 63:195-203. full_text, 19955787.
4. Hayden MR. Islet amyloid, metabolic syndrome, and the natural progressive history of type 2 diabetes mellitus. J Pancreas 2002, 3:126-138.
5. Proietto J, Andrikopoulos S, Rosella G, Thorburn A. Understanding the pathogenesis of type 2 diabetes: can we get off the metabolic merry-go-rounds?. Aust N Z J Med 1995, 25:870-875.
6. Galli J, Fakhrai-Rad H, Kamel A, Marcus C, Norgren S, Luthman H. Pathophysiological and genetic characterization of the major diabetes locus in GK rats. Diabetes 1999, 48:2463-2470. 10.2337/diabetes.48.12.2463, 10580437.
7. Gauguier D, Froguel P, Parent V, Bernard C, Bihoreau MT, Portha B, James MR, Penicaud L, Lathrop M, Ktorza A. Chromosomal mapping of genetic loci associated with non-insulin dependent diabetes in the GK rat. Nat Genet 1996, 12:38-43. 10.1038/ng0196-38, 8528248.
8. Permutt MA, Wasson J, Cox N. Genetic epidemiology of diabetes. J Clin Invet 2005, 115:1431-1439.
9. Chen L, Wang RS, Zhang X. Biomolecular Networks: Methods and Applications in Systems Biology. 2009, John Wiley & Sons.
10. Chen L, Wang RQ, Li G, Aihara K. Modeling Biomolecular Networks in Cells: Structures and Dynamics. 2010, Springer-Verlag.
11. Saito S, Aburatani S, Horimoto K. Network evaluation from the consistency of the graph structure with the measured data. BMC Sys Biol 2008, 2:84.
12. Almon RR, DuBois DC, Lai W, Xue B, Nie J, Jusko WJ. Gene expression analysis of hepatic roles in cause and development of diabetes in Goto-Kakizaki rats. J Endocrinol 2009, 200:331-346. 10.1677/JOE-08-0404, 19074471.
13. Wingender E. TRANSFAC project as an example of framework technology that supports the analysis of genomic regulation. Brief. Bioinformatics 2008, 326-332. 10.1093/bib/bbn016, 18436575.
14. Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA, Paulovich A, Pomeroy SL, Golub TR, Lander ES, Mesirov JP. Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl. Acad. Sci. USA 2005, 102:15545-15550. 10.1073/pnas.0506580102, 1239896, 16199517.
15. Pearl J. Probabilistic Reasoning in Intelligent Systems. 1988, California, Kaufmann Morgan Publishers.
16. Whittaker J. Graphical Models in Applied Multivariate Statistics. 1990, New York, John Wiley and Sons.
17. Coles S. An Introduction to Statistical Modeling of Extreme Values. 2001, London, Springer-Verlag.
18. Lee NK, Sowa H, Hinoi E, Ferron M, Ahn JD, Confavreux C, Dacquin R, Mee PJ, McKee MD, Jung DY, Zhang Z, Kim JK, Mauvais-Jarvis F, Ducy P, Karsenty G. Endocrine regulation of energy metabolism by the skeleton. Cell 2007, 130:456-469. 10.1016/j.cell.2007.05.047, 2013746, 17693256.
19. Beijers HJ, Losekoot M, Odink RJ, Bravenboer B. Hepatocyte nuclear factor (HNF)1A and HNF4A substitution occurring simultaneously in a family with maturity-onset diabetes of the young. Diabet Med 2009, 26:1172-1174. 10.1111/j.1464-5491.2009.02855.x, 19929997.
20. Nikkilä EA, Huttunen JK, Ehnholm C. Postheparin plasma lipoprotein lipase and hepatic lipase in diabetes mellitus. Relationship to plasma triglyceride metabolism. Diabetes 1977, 26:11-21. 10.2337/diabetes.26.1.11, 187516.
21. Das B, Pawar N, Saini D, Seshadri M. Genetic association study of selected candidate genes (ApoB, LPL, Leptin) and telomere length in obese and hypertensive individuals. BMC Med Genet 2009, 10:99. 10.1186/1471-2350-10-99, 2754983, 19772655.
22. Greenhalgh CJ, Rico-Bautista E, Lorentzon M, Thaus AL, Morgan PO, Willson TA, Zervoudakis P, Metcalf D, Street I, Nicola NA, Nash AD, Fabri LJ, Norstedt G, Ohlsson C, Flores-Morales A, Alexander WS, Hilton DJ. SOCS2 negatively regulates growth hormone action in vitro and in vivo. J Clin Invest 2005 8211, 115:397-406.
23. Turnley AM, Faux CH, Rietze RL, Coonan JR, Bartlett PF. Suppressor of cytokine signaling 2 regulates neuronal differentiation by inhibiting growth hormone signaling. Nature Neuroscience 2002, 5:1155-1162. 10.1038/nn954, 12368809.
24. Haluzik M, Yakar S, Gavrilova O, Setser J, Boisclair Y, LeRoith D. Insulin Resistance in the Liver-Specific IGF-1 Gene-Deleted Mouse Is Abrogated by Deletion of the Acid-Labile Subunit of the IGF-Binding Protein-3 Complex Relative Roles of Growth Hormone and IGF-1 in Insulin Resistance. Diabetes 2003, 52:2483-2489. 10.2337/diabetes.52.10.2483, 14514630.
25. Rui L, Yuan M, Frantz D, Shoelson S, White MF. SOCS-1 and SOCS-3 block insulin signaling by ubiquitin-mediated degradation of IRS1 and IRS2. J Biol Chem 2002, 277:42394-42398. 10.1074/jbc.C200444200, 12228220.
26. Bolscher BG, de Boer M, de Klein A, Weening RS, Roos D. Point mutations in the beta-subunit of cytochrome b558 leading to X-linked chronic granulomatous disease. Blood 1991, 77:2482-2487.
27. Fan F, Jin S, Amundson SA, Tong T, Fan W, Zhao H, Zhu X, Mazzacurati L, Li X, Petrik KL, Fornace AJ, Rajasekaran B, Zhan Q. ATF3 induction following DNA damage is regulated by distinct signaling pathways and over-expression of ATF3 protein suppresses cells growth. Oncogene 2002, 1:7488-7496.
28. Kannanayakal TJ, Mendell JR, Kuret J. Casein Kinase 1 alpha associates with the tau-bearing lesions of inclusion body myositis. Neurosci Lett 2008, 431:141-145. 10.1016/j.neulet.2007.11.066, 2359895, 18191026.
29. Bereczky Z, Katona E, Muszbek L. Fibrin stabilization (factor XIII), fibrin structure and thrombosis. Pathophysiol Haemost Thromb 2005, 33:430-437.
30. Matsuura E, Kobayashi K, Matsunami Y, Lopez LR. The immunology of atherothrombosis in the antiphospholipid syndrome: antigen presentation and lipid intracellular accumulation. Autoimmun Rev 2009, 8:500-505. 10.1016/j.autrev.2008.12.018, 19171205.
31. Auwerx J, Bouillon R, Collen D, Geboers J. Tissue-type plasminogen activator antigen and plasminogen activator inhibitor in diabetes mellitus. Arteriosclerosis 1988, 8:68-72.
32. Briggs SD, Bryant SS, Jove R, Sanderson SD, Smithgall TE. The Ras GTPase-activating protein (GAP) is an SH3 domain-binding protein and substrate for the Src-related tyrosine kinase, Hck. J. Biol. Chem 1995, 24:14718-14724.
33. Claus V, Jahraus A, Tjelle T, Berg T, Kirschke H, Faulstich H, Griffiths G. Lysosomal enzyme trafficking between phagosomes, endosomes, and lysosomes in J774 macrophages. Enrichment of cathepsin H in early endosomes. J. Biol. Chem 1998, 273:9842-9851. 10.1074/jbc.273.16.9842, 9545324.
34. Kosters A, Jirsa M, Groen AK. Genetic background of cholesterol gallstone disease. Biochim Biophys Acta 2003, 1637:1-19.
35. Nadler ST, Stoehr JP, Schueler KL, Tanimoto G, Yandell BS, Attie AD. The expression of adipogenic genes is decreased in obesity and diabetes mellitus. Proc Natl Acad Sci U S A 2000, 97:11371-11376. 10.1073/pnas.97.21.11371, 17207, 11027337.
36. Geisler JG, Zawalich W, Zawalich K, Lakey JR, Stukenbrok H, Milici AJ, Soeller WC. Estrogen Can Prevent or Reverse Obesity and Diabetes in Mice Expressing Human Islet Amyloid Polypeptide. Diabetes 2002, 7:2158-2169.
37. Kalyani RR, Dobs AS. Androgen deficiency, Diabetes, and the metabolic syndrome in men. Curr Opin Endocrinol Diabetes Obes 2007, 14:226-234. 10.1097/MED.0b013e32814db856, 17940444.
38. Lefebvre B, Benomar Y, Guédin A, Langlois A, Hennuyer N, Dumont J, Bouchaert E, Dacquet C, Pénicaud L, Casteilla L, Pattou F, Ktorza A, Staels B, Lefebvre P. Proteasomal degradation of retinoid X receptor alpha reprograms transcriptional activity of PPARgamma in obese mice and humans. J Clin Invest 2010, 120:1454-1468. 10.1172/JCI38606, 2860909, 20364085.
39. Chin JE, Liu F, Roth RA. Activation of protein kinase C alpha inhibits insulin-stimulated tyrosine phosphorylation of insulin receptor substrate-1. Mol Endocrinol 1994, 8:51-58. 10.1210/me.8.1.51, 7512195.
40. Chuang HY, Lee E, Liu YT, Lee D, Ideker T. Network-based classification of breast cancer metastasis. Mol Sys Biol 2007, 3:140.
41. Lei HB, Zhang JF, Chen L. Multi-equilibrium property of metabolic networks: SSI module. BMC Sys Biol 2010, 5(Suppl 1):S15.